Literature DB >> 10493301

Global perspective of tobacco habits and lung cancer: a lesson for third world countries.

M Pandey1, A Mathew, M K Nair.   

Abstract

Over the past 50 years, a dominant role of tobacco smoking in lung cancer causation has been demonstrated. Almost three-quarters of the lung cancer cases can be attributed to tobacco smoking. The global variation in lung cancer incidence is thought to be directly proportional to the smoking habits prevalent in that part of the world. Lung cancer shows a greater upward trend in incidence in the USA, in central and Eastern Europe than ever before, especially in females. Japan too has recorded a 10-fold increase in incidence in both sexes since 1975. In India the problem is further compounded by absence of authentic data on time trend. The recent trend of available data suggests a more or less linear trend. At present lung cancer ranks among the top three killers in men in almost every metropolis in India. The highest incidence rate has been recorded in Bombay (14.6/ 100,000) and the lowest in Barshi (2.0/100,000). How much of these can be attributed to smoking cannot be commented on as no case-control or cohort studies have ever been undertaken in India. The situation is more alarming in other developing countries, where there is no authentic data on tobacco use or lung cancer incidences. The relationship between tobacco and cancer is both simple and complex. The majority of the cancer patients are smokers, while the cancer incidence is not proportional among smokers. To explain this, various factors such as type of smoke, duration of smoke, amount of carcinogens, presence of activation and metabolism pathways, and lately genetic environment interaction, have been put forward. It appears that the relationship is more complex than at first thought. In developing countries, it is further compounded by lack of data on usage and dependence of the economies of these countries on tobacco. The situation is alarming, with ever-increasing incidence among women and non-smokers exposed to smoke (passive smokers). Tobacco use has already become an epidemic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493301     DOI: 10.1097/00008469-199908000-00002

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

1.  Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation.

Authors:  Robert A Schnoll; Paul F Engstrom; Somasundaram Subramanian; Lev Demidov; Dustin B Wielt
Journal:  Int J Behav Med       Date:  2006

Review 2.  Carcinoma of the bronchus 60 years later.

Authors:  G A Silvestri; S G Spiro
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

3.  Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.

Authors:  Chien-Min Chen; Yi-Hsien Hsieh; Jin-Ming Hwang; Hsun-Jin Jan; Shu-Ching Hsieh; Shin-Huey Lin; Chung-Yu Lai
Journal:  Tumour Biol       Date:  2014-12-20

4.  Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.

Authors:  M Huang; R K Batra; T Kogai; Y Q Lin; J M Hershman; A Lichtenstein; S Sharma; L X Zhu; G A Brent; S M Dubinett
Journal:  Cancer Gene Ther       Date:  2001-08       Impact factor: 5.987

5.  Licochalcone A inhibits the migration and invasion of human lung cancer cells via inactivation of the Akt signaling pathway with downregulation of MMP-1/-3 expression.

Authors:  Hung-Che Huang; Lo-Lin Tsai; Jen-Pi Tsai; Shu-Ching Hsieh; Shun-Fa Yang; Jung-Tsung Hsueh; Yi-Hsien Hsieh
Journal:  Tumour Biol       Date:  2014-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.